We are excited to announce a new partnership with iCAD, a global leader in AI-powered cancer detection technologies. This collaboration will integrate iCAD's ProFound AI® Breast Health Suite into deepcOS®, advancing our mission to improve clinical workflows and elevate healthcare standards through innovative artificial intelligence solutions.
With this partnership, ProFound AI® will be available in the vendor-neutral deepcOS® AI Portfolio, giving radiologists and healthcare providers seamless access to iCAD's advanced AI tools directly within their current diagnostic systems. Leveraging deepc’s cloud-based infrastructure, this integration offers a scalable, secure, and efficient means for healthcare institutions to adopt ProFoundAI® without additional hardware or technical complications.
ProFound AI® Detection: A deep learning-powered platform designed to enhance the detection of breast cancer using both 2D and 3D mammography. Clinically proven to improve sensitivity by 8%, reduce false positives, and cut reading times by over 50%, ProFound AI® enables radiologists to detect cancers more accurately and efficiently.
This partnership aims to improve diagnostic accuracy and optimize radiology workflows, empowering healthcare providers to deliver higher-quality care more efficiently. By integrating iCAD’s leading AI technologies, deepcOS® users can access industry-proven tools that optimize breast cancer detection, risk assessment, and density evaluation without disrupting existing workflows.
iCAD’s Global Impact iCAD’s ProFound AI® has been implemented in over 50 countries globally, with real-world data demonstrating significant improvements in cancer detection rates and diagnostic accuracy. Through this collaboration, deepcOS® users will benefit from iCAD's extensive experience in AI-driven innovations, furthering deepc’s commitment to providing healthcare facilities with high-quality, easy-to-implement solutions that enhance operational efficiency and patient outcomes.
Together, deepc and iCAD are addressing critical challenges in radiology, such as improving early cancer detection and reducing radiologists' workloads. This partnership underscores our shared commitment to advancing patient care by providing cutting-edge, AI-driven healthcare solutions.